Thermo Fisher Scientific Accrued Expenses increased by 3.7% to $3.33B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.1%, from $3.20B to $3.33B. Over 5 years (FY 2020 to FY 2025), Accrued Expenses shows an upward trend with a 7.5% CAGR.
Rising accruals often track with headcount growth or increased operational activity.
Liabilities representing expenses that have been incurred but not yet paid or invoiced, such as employee wages, interest...
Standard across all industries; usually scales linearly with the size of the workforce and operations.
accrued_expenses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.86B | $2.18B | $2.95B | $3.03B | $2.96B | $3.21B | $3.35B | $3.00B | $2.98B | $2.85B | $3.25B | $2.99B | $3.02B | $3.39B | $3.20B | $3.02B | $3.20B | $3.21B | $3.33B |
| QoQ Change | — | +16.9% | +35.6% | +2.8% | -2.5% | +8.4% | +4.6% | -10.7% | -0.7% | -4.3% | +14.0% | -8.0% | +1.1% | +12.4% | -5.7% | -5.5% | +5.9% | +0.3% | +3.7% |
| YoY Change | — | — | — | — | +58.9% | +47.4% | +13.7% | -1.2% | +0.6% | -11.2% | -3.2% | -0.3% | +1.5% | +19.1% | -1.4% | +1.2% | +6.0% | -5.4% | +4.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.